Dr Jindriska Lindsay

Dr Jin Lindsay is a Consultant Haematologist with a specialist focus on the diagnosis and management of myeloma, Waldenström’s macroglobulinemia and associated conditions. She sees patients at GenesisCare Maidstone, where she provides treatment as part of a collaborative team focused on delivering high-quality, individualised care.

Dr Lindsay completed her specialist training in Haematology on the King’s College Hospital London rotation, a nationally recognised programme for its excellence in haematological research and clinical practice. She joined East Kent Hospitals University NHS Foundation Trust in 2010 and is based at Kent and Canterbury Hospital, where she continues to contribute to both clinical care and service development. She has joined the Neuro-haematology team at the National Hospital for Neurology and Neurosurgery in 2016 focusing on diagnosis and management of paraprotein related neurological disorders. Since 2023 she is also member of the national referral centre for WM and related disorders team at UCLH.

Her clinical interests centre on complex plasma cell disorders, particularly multiple myeloma and Waldenström’s Macroglobulinaemia. As Principal Investigator for several myeloma clinical trials across East Kent, Dr Lindsay plays a key role in facilitating access to novel therapies and supporting the integration of research into routine practice. Due to her significant contribution in clinical research she is recognised nationally and internationally, she has co-authored papers published in high impact journals such as NEJM and Lancet.

In addition to her research activities, Dr Lindsay is actively involved in shaping haematology services within the NHS Trust. She contributes to the development of clinical pathways and protocols aimed at improving patient safety, treatment outcomes, and service efficiency.

Dr Lindsay is known for her clear and compassionate communication style, supporting patients and families through complex treatment decisions. She is fluent in Czech and English and maintains professional membership with the British Society for Haematology and the European Haematology Association.